FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

LOTUS EYE HOSPITAL AND INSTITUTE LTD.

NSE : LOTUSEYEBSE : 532998ISIN CODE : INE947I01017Industry : Hospital & Healthcare ServicesHouse : Private

BSE121.955.8 (+4.99 %)

PREV CLOSE (Rs.) 116.15

OPEN PRICE (Rs.) 121.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1292

TODAY'S LOW / HIGH (Rs.)117.55 121.95

52 WK LOW / HIGH (Rs.)55.31 140.9

NSE122.175.8 (+4.98 %)

PREV CLOSE( Rs. ) 116.37

OPEN PRICE (Rs.) 121.45

BID PRICE (QTY) 122.17 (40)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 26863

TODAY'S LOW / HIGH(Rs.) 119.57 122.18

52 WK LOW / HIGH (Rs.)54.99 139.2

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

1.57

Dividend Yield(%)

0.00

TTM EPS (Rs.)

0.33

P/E Ratio

374.61

Book Value (Rs.)

29.15

Face Value (Rs.)

MCap (Rs. in Mn)

2536.11

Price/Earning (TTM)

82.72

Price/Sales (TTM)

5.04

Price/Book (MRQ)

4.18

PAT Margin (%)

1.49

ROCE (%)

3.10

Incorporation Year : 14-03 1997

Management Info :

Kavetha Sundaramoorthy - Chairman Sangeetha Sundaramoorthy - Managing Director

Registered Office :

Address : S F No 770 / 12,Civil Aerodrome Post,Avinashi Road,
Coimbatore,
Tamil Nadu-641014

Phone : 0422 4229900 / 99

Email : companysecretary@lotuseye.org

Website : www.lotuseye.org

Registrars Details :

MUFG Intime India Pvt Ltd.

Surya, 35 Mayflower Avenue,Behind Senthil Nagar,Sowripalayam Road,Coimbatore

Listing : BSE, NSE

NEWS

19Jan Lotus Eye Hospital and Institute infor
Pursuant to Regulation 44(3) of SEBI LODR 2015 read with Section 110 of..

08Dec Lotus Eye Hospital And Institute infor
Lotus Eye Hospital And Institute has informed that Bombay Stock Exchange..

22Sep Lotus Eye Hospital And Institute infor
Lotus Eye Hospital And Institute has informed that the exchange has rece..

Financials

	QTR Sep 25	ANNUAL 25
Net Profit	1.16	7.40999999999996
Gross Profit	0.730000000000002	13.84
Operating Profit	10.42	47.36
Net Sales	130.38	495.62

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Nephrocare Health Se (BSE)

509.15 (2.57%)

M.Cap (Rs. in Cr)5108.85

RainbowChildrenS Med (BSE)

1185.85 (0.71%)

M.Cap (Rs. in Cr)12043.39

Vijaya Diagnostic (BSE)

996.20 (0.60%)

M.Cap (Rs. in Cr)9632.71

Krsnaa Diagnostics (BSE)

715.10 (0.74%)

M.Cap (Rs. in Cr)2319.69

Shareholding Pattern

	NON-INSTITUTION	57.88%
	PROMOTERS	39.67%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

No Data Found

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

close X

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Assamese Bengali Gujarati Hindi Kanada

Kashmiri Konkani Malyalam Marathi Oriya

Punjabi Sindhi Tamil Telegu Urdu

NOTE : " This document is a translated version of the client registration documents in English and is being provided in vernacular language to facilitate better understanding by the investors. In case of any ambiguity, the contents of the English version would prevail. "

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22